Literature DB >> 23825172

Optic nerve head component responses of the multifocal electroretinogram in MS.

Teresa C Frohman1, Shin Chien Beh, Shiv Saidha, Zane Schnurman, Darrel Conger, Amy Conger, John N Ratchford, Carmen Lopez, Steven L Galetta, Peter A Calabresi, Laura J Balcer, Ari J Green, Elliot M Frohman.   

Abstract

OBJECTIVE: To employ a novel stimulation paradigm in order to elicit multifocal electroretinography (mfERG)-induced optic nerve head component (ONHC) responses, believed to be contingent upon the transformation in electrical transmission properties of retinal ganglion cell axons from membrane to saltatory conduction mechanisms, as they traverse the lamina cribrosa and obtain oligodendrocyte myelin. We further sought to characterize abnormalities in ONHC responses in eyes from patients with multiple sclerosis (MS).
METHODS: In 10 normal subjects and 7 patients with MS (including eyes with and without a history of acute optic neuritis), we utilized a novel mfERG stimulation paradigm that included interleaved global flashes in order to elicit the ONHC responses from 103 retinal patches of pattern-reversal stimulation.
RESULTS: The number of abnormal or absent ONHC responses was significantly increased in MS patient eyes compared to normal subject eyes (p < 0.001, by general estimating equation modeling, and accounting for age and within-subject, intereye correlations).
CONCLUSION: Studying the relationship between ONHC abnormalities and alterations in validated structural and functional measures of the visual system may facilitate the ability to dissect and characterize the pathobiological mechanisms that contribute to tissue damage in MS, and may have utility to detect and monitor neuroprotective or restorative effects of novel therapies.

Entities:  

Mesh:

Year:  2013        PMID: 23825172      PMCID: PMC3775685          DOI: 10.1212/WNL.0b013e31829e6faa

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  The optic nerve head component of the monkey's (Macaca mulatta) multifocal electroretinogram (mERG).

Authors:  D C Hood; M A Bearse; E E Sutter; S Viswanathan; L J Frishman
Journal:  Vision Res       Date:  2001-07       Impact factor: 1.886

2.  The optic nerve head component of the human ERG.

Authors:  E E Sutter; M A Bearse
Journal:  Vision Res       Date:  1999-02       Impact factor: 1.886

3.  Selective loss of an oscillatory component from temporal retinal multifocal ERG responses in glaucoma.

Authors:  Brad Fortune; Marcus A Bearse; George A Cioffi; Chris A Johnson
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-08       Impact factor: 4.799

4.  Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis.

Authors:  Stephanie B Syc; Shiv Saidha; Scott D Newsome; John N Ratchford; Michael Levy; E'tona Ford; Ciprian M Crainiceanu; Mary K Durbin; Jonathan D Oakley; Scott A Meyer; Elliot M Frohman; Peter A Calabresi
Journal:  Brain       Date:  2011-10-17       Impact factor: 13.501

5.  The field topography of ERG components in man--I. The photopic luminance response.

Authors:  E E Sutter; D Tran
Journal:  Vision Res       Date:  1992-03       Impact factor: 1.886

6.  Intertest variability of mfVEP amplitude: reducing its effect on the interpretation of sequential tests.

Authors:  A Klistorner; S L Graham
Journal:  Doc Ophthalmol       Date:  2006-03-06       Impact factor: 2.379

7.  Evidence for a ganglion cell contribution to the primate electroretinogram (ERG): effects of TTX on the multifocal ERG in macaque.

Authors:  D C Hood; L J Frishman; S Viswanathan; J G Robson; J Ahmed
Journal:  Vis Neurosci       Date:  1999 May-Jun       Impact factor: 3.241

8.  Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.

Authors:  Chris H Polman; Stephen C Reingold; Brenda Banwell; Michel Clanet; Jeffrey A Cohen; Massimo Filippi; Kazuo Fujihara; Eva Havrdova; Michael Hutchinson; Ludwig Kappos; Fred D Lublin; Xavier Montalban; Paul O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Emmanuelle Waubant; Brian Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2011-02       Impact factor: 10.422

  8 in total
  5 in total

1.  Retinal architecture and mfERG: Optic nerve head component response characteristics in MS.

Authors:  Zane S Schnurman; Teresa C Frohman; Shin C Beh; Darrel Conger; Amy Conger; Shiv Saidha; Steven Galetta; Peter A Calabresi; Ari J Green; Laura J Balcer; Elliot M Frohman
Journal:  Neurology       Date:  2014-04-30       Impact factor: 9.910

2.  Retinal Architecture and Melanopsin-Mediated Pupillary Response Characteristics: A Putative Pathophysiologic Signature for the Retino-Hypothalamic Tract in Multiple Sclerosis.

Authors:  Ethan Meltzer; Peter V Sguigna; Adnan Subei; Shin Beh; Eric Kildebeck; Darrel Conger; Amy Conger; Marlen Lucero; Benjamin S Frohman; Ashley N Frohman; Shiv Saidha; Steven Galetta; Peter A Calabresi; Robert Rennaker; Teresa C Frohman; Randy H Kardon; Laura J Balcer; Elliot M Frohman
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

Review 3.  The investigation of acute optic neuritis: a review and proposed protocol.

Authors:  Axel Petzold; Mike P Wattjes; Fiona Costello; Jose Flores-Rivera; Clare L Fraser; Kazuo Fujihara; Jacqueline Leavitt; Romain Marignier; Friedemann Paul; Sven Schippling; Christian Sindic; Pablo Villoslada; Brian Weinshenker; Gordon T Plant
Journal:  Nat Rev Neurol       Date:  2014-07-08       Impact factor: 42.937

4.  Acute optic neuritis: a clinical paradigm for evaluation of neuroprotective and restorative strategies?

Authors:  Sara S Qureshi; Elliot M Frohman
Journal:  Neural Regen Res       Date:  2015-10       Impact factor: 5.135

Review 5.  Re-evaluating the treatment of acute optic neuritis.

Authors:  Jeffrey L Bennett; Molly Nickerson; Fiona Costello; Robert C Sergott; Jonathan C Calkwood; Steven L Galetta; Laura J Balcer; Clyde E Markowitz; Timothy Vartanian; Mark Morrow; Mark L Moster; Andrew W Taylor; Thaddeus W W Pace; Teresa Frohman; Elliot M Frohman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-10-29       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.